{
    "doi": "https://doi.org/10.1182/blood.V128.22.4692.4692",
    "article_title": "Long Term Follow up and Impact of Comorbidity Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory AML - Lessons Learned from the Prospective Bridge Trial - ",
    "article_date": "December 2, 2016",
    "session_type": "732. Clinical Allogeneic Transplantation: Results: Poster III",
    "abstract_text": "In patients with relapsed or refractory (r/r) Acute Myeloid Leukemia (AML), allogeneic Hematopoietic Stem Cell Transplantation (HSCT) is considered to be the only treatment providing long-term disease control for fit patients. The BRIDGE trial studied the safety and efficacy of a clofarabine-based salvage therapy prior to HSCT in patients with r/r AML. Here, we report the long-term follow up of this Phase II, multi-center, Intent-To-Transplant study and the impact of comorbidity on outcome. Eighty-four patients with a median age of 61 years (range 40 - 75) were enrolled. Patients were scheduled for at least one cycle of salvage therapy with CLARA (clofarabine 30 mg/m2 and cytarabine 1 g/m2, days 1-5). Chemo-responsive patients with a donor received HSCT after first CLARA. In the event of a prolonged donor search, HSCT was performed as soon as possible. The conditioning regimen consisted of clofarabine 30 mg/m2, day -6 to -3, and melphalan 140 mg/m2 on day -2. The ECOG score, hematopoietic cell transplantation-specific comorbidity index (HCT-CI) and Cumulative Illness Rating scale (CIRS) were obtained at study enrolment as well as prior to HSCT. Sixty-seven percent of the patients received HSCT within the trial. After a median follow up of 40 months (95% CI, 38-49 months), the estimated 4-year OS (Figure 1) for all enrolled patients was 38% (95% CI, 28-50%) and Disease-Free Survival for transplanted patients was 48% (95% CI, 36-64%). The CIR at four years was 30% (95% CI, 17-43%) and the NRM 22% (95% CI, 10-33%). Those patients who received an allogeneic HSCT within the trial had a median HCT-CI at the time of study enrollment of 1 (range, 0 - 6) compared to a median of 2 (range, 0 - 6) for those who did not proceed to allogeneic HSCT ( p = .17). Corresponding figures for the CIRS were a median of 2 (range, 0 - 9) compared to 4 (range, 0 - 8) ( p = .09). The median ECOG score was 1 (range, 0 - 3) in both groups. Compared to the time point of study enrollment, both the HCT-CI as well as the CIRS increased to a median of 2 (observed range of score, 0 - 7) and a median of 4 (observed range of score, 0 - 12), respectively, at the time of start of the conditioning regimen. This was almost exclusively due to an increase in infectious complications (Figure 2). In multivariate analysis , both the baseline HCT-CI and the ECOG score had a statistically significant impact with a HR of 1.22 (p = .025) and 1.72 (p = .001), respectively, on OS. Using a clofarabine-based salvage therapy combined with early allogeneic HSCT we were able to achieve good long-term results for patients with r/r AML. In this cohort, both the HCT-CI and the ECOG score gave prognostic information on OS, showing feasibility of comorbidity evaluation at the time of diagnose of r/r AML. Figure 1 View large Download slide OS of all enrolled patients Figure 1 View large Download slide OS of all enrolled patients Close modal Figure 2 View large Download slide Changes of the HCT-CI at baseline to HSCT Figure 2 View large Download slide Changes of the HCT-CI at baseline to HSCT Close modal Disclosures Middeke: Sanofi: Honoraria. R\u00f6sler: Janssen: Consultancy, Other: Travel/Accommodation/Expenses. Thiede: AgenDix: Employment, Other: Ownership. Schetelig: Sanofi: Honoraria.",
    "topics": [
        "allogeneic hematopoietic stem cell transplant",
        "comorbidity",
        "follow-up",
        "hematopoietic stem cell transplantation",
        "clofarabine",
        "electrocorticogram",
        "salvage therapy",
        "transplantation",
        "chemotherapy regimen",
        "cytarabine"
    ],
    "author_names": [
        "Jan Moritz Middeke, MD",
        "Regina Herbst, MD",
        "Stefani Barbara Parmentier, MD",
        "Gesine Bug, MD",
        "Mathias H\u00e4nel, MD",
        "Gernot Stuhler",
        "Kerstin Sch\u00e4fer-Eckart, MD",
        "Wolf R\u00f6sler, MD",
        "Stefan A. Klein, MD",
        "Wolfgang Bethge, MD",
        "Nael Alakel, MD",
        "Markus Schaich, MD",
        "Anke Morgner, MD",
        "Michael Kramer, MSc",
        "Katja Sockel, MD",
        "Malte von Bonin, MD",
        "Friedrich St\u00f6lzel, MD",
        "Uwe Platzbecker, MD",
        "Christoph R\u00f6llig, MD",
        "Christian Thiede, MD",
        "Gerhard Ehninger, MD",
        "Martin Bornh\u00e4user, MD",
        "Johannes Schetelig, MD MSc"
    ],
    "author_dict_list": [
        {
            "author_name": "Jan Moritz Middeke, MD",
            "author_affiliations": [
                "Medizinische Klinik und Poliklinik I, Universit\u00e4tsklinikum Carl Gustav Carus, Dresden, Germany "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Regina Herbst, MD",
            "author_affiliations": [
                "Medizinische Klinik III, Klinikum Chemnitz, Chemnitz, Germany "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Stefani Barbara Parmentier, MD",
            "author_affiliations": [
                "Klinik f\u00fcr H\u00e4matologie, Onkologie und Palliativmedizin, Rems-Murr-Klinikum Winnenden, Waiblingen, DEU "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Gesine Bug, MD",
            "author_affiliations": [
                "Department of Medicine, Hematology/Oncology, University of Frankfurt, Frankfurt, Germany "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mathias H\u00e4nel, MD",
            "author_affiliations": [
                "Klinik f\u00fcr Innere Medizin III, Klinikum Chemnitz, Chemnitz, Germany "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Gernot Stuhler",
            "author_affiliations": [
                "Zentrum f\u00fcr Blutstammzell- und Knochenmarktransplantation, DKD Helios Klinik Wiesbaden, Wiesbaden, Germany "
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Kerstin Sch\u00e4fer-Eckart, MD",
            "author_affiliations": [
                "5. Medizinische Klinik, St\u00e4dtisches Klinikum Nord, N\u00fcrnberg, Germany "
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Wolf R\u00f6sler, MD",
            "author_affiliations": [
                "Medizinische Klinik 5, Universit\u00e4tsklinkum Erlangen, Erlangen, Germany "
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Stefan A. Klein, MD",
            "author_affiliations": [
                "III. Medizinische Klinik, Universit\u00e4tsmedizin Mannheim, Mannheim, Germany "
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Wolfgang Bethge, MD",
            "author_affiliations": [
                "Department of Hematology and Oncology, Eberhard Karls University Tuebingen, Tuebingen, Germany "
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Nael Alakel, MD",
            "author_affiliations": [
                "Department of Internal Medicine I, Universit\u00e4tsklinikum Carl Gustav Carus, Dresden, Germany "
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Markus Schaich, MD",
            "author_affiliations": [
                "Klinik f\u00fcr H\u00e4matologie, Onkologie und Palliativmedizin, Rems-Murr-Klinikum Winnenden, Winnenden, Germany "
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Anke Morgner, MD",
            "author_affiliations": [
                "Medizinische Klinik III, Klinikum Chemnitz, Chemnitz, Germany "
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Michael Kramer, MSc",
            "author_affiliations": [
                "Medizinische Klinik und Poliklinik I, Universit\u00e4tsklinikum Carl Gustav Carus, Dresden, Germany "
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Katja Sockel, MD",
            "author_affiliations": [
                "Medizinische Klinik und Poliklinik I, Universit\u00e4tsklinikum Carl Gustav Carus, Dresden, Germany "
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Malte von Bonin, MD",
            "author_affiliations": [
                "Medizinische Klinik und Poliklinik I, Universit\u00e4tsklinikum Carl Gustav Carus, Dresden, Germany "
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Friedrich St\u00f6lzel, MD",
            "author_affiliations": [
                "Medizinische Klinik und Poliklinik I, Universit\u00e4tsklinikum Carl Gustav Carus, Dresden, Germany "
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Uwe Platzbecker, MD",
            "author_affiliations": [
                "Medizinische Klinik und Poliklinik I, Universit\u00e4tsklinikum Carl Gustav Carus, Dresden, Germany "
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Christoph R\u00f6llig, MD",
            "author_affiliations": [
                "Medizinische Klinik und Poliklinik I, Universit\u00e4tsklinikum Carl Gustav Carus, Dresden, Germany "
            ],
            "author_rank": 19,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Christian Thiede, MD",
            "author_affiliations": [
                "Medizinische Klinik und Poliklinik I, Universit\u00e4tsklinikum Carl Gustav Carus, Dresden, Germany "
            ],
            "author_rank": 20,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Gerhard Ehninger, MD",
            "author_affiliations": [
                "Medizinische Klinik und Poliklinik I, Universit\u00e4tsklinikum Carl Gustav Carus, Dresden, Germany "
            ],
            "author_rank": 21,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Martin Bornh\u00e4user, MD",
            "author_affiliations": [
                "Department of Internal Medicine I, Universit\u00e4tsklinikum Carl Gustav Carus, Dresden, Germany "
            ],
            "author_rank": 22,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Johannes Schetelig, MD MSc",
            "author_affiliations": [
                "Department of Internal Medicine I, Universit\u00e4tsklinikum Carl Gustav Carus, Dresden, Germany ",
                "DKMS Clinical Trials Unit, Dresden, Germany"
            ],
            "author_rank": 23,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-06-06T18:46:29",
    "is_scraped": "1"
}